BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCTX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BCTX · as of Sep 30, 2025
Ownership Breakdown
12
Institutional Holders
▲ 12 vs Q2
$136,489
Total Inst. Value
▲ $136,489 vs Q2
1.88M
Shares Outstanding
freeFloat 88.42%
12,427
13F Shares Held
▲ 12,427 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BCTX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CITADEL ADVISORS LLC pharmaceutical preparations | 11.1K | 58.68% | 58.68% | $121.61M | Nov 14, 2025 | NEW |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC pharmaceutical preparations | 905 | 4.80% | 4.80% | $9.84M | Nov 14, 2025 | NEW |
MORGAN STANLEY pharmaceutical preparations | 114 | 0.61% | 0.61% | $1.25M | May 27, 2026 | NEW |
ROYAL BANK OF CANADA pharmaceutical preparations | 100 | 0.53% | 0.53% | $1.00M | Nov 14, 2025 | NEW |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 80 | 0.42% | 0.42% | $880,000 | Nov 5, 2025 | NEW |
GROUP ONE TRADING, L.P. pharmaceutical preparations | 70 | 0.37% | 0.37% | $770,000 | Nov 12, 2025 | NEW |
UBS GROUP AG pharmaceutical preparations | 64 | 0.34% | 0.34% | $704,000 | Nov 13, 2025 | NEW |
TD WATERHOUSE CANADA INC. pharmaceutical preparations | 19 | 0.10% | 0.10% | $238,000 | Nov 3, 2025 | NEW |
ALLWORTH FINANCIAL LP pharmaceutical preparations | 7 | 0.04% | 0.04% | $77,000 | Dec 2, 2025 | NEW |
HHM WEALTH ADVISORS, LLC pharmaceutical preparations | 6 | 0.03% | 0.03% | $66,000 | Oct 29, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
0
Increased
+0 shares12
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+12
12 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BCTX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Lustig Marc
| May 14, 2024 | Purchase | 902,935 | $2.21 | $2.00M | 2.54M | Form 4 ↗ |
Lustig Marc
| May 14, 2024 | Purchase | 902,935 | $2.11 | $1.91M | 902.9K | Form 4 ↗ |
Bondarenko Jamieson Chairman | Dec 28, 2022 | Purchase | 28,000 | $4.58 | $128.2K | 169.9K | Form 4 ↗ |
Williams William V. President, CEO | Dec 23, 2022 | Purchase | 2,530 | $1.94 | $4.9K | 29.8K | Form 4 ↗ |
Bondarenko Jamieson director | Dec 20, 2022 | Purchase | 22,000 | $5.35 | $117.7K | 141.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
BriaCell Therapeutics Corp. (BCTX) is primarily owned by institutional investors, who hold approximately 0.7% of total shares outstanding. Company insiders own approximately 11.58%, while retail and public investors account for the remaining 87.76%.
The largest institutional shareholder of BriaCell Therapeutics Corp. is CITADEL ADVISORS LLC, holding approximately 11,055 shares — equal to 58.68% of outstanding shares — as of September 30, 2025.
A total of 12 institutional investors currently hold BCTX stock, with a combined institutional value of approximately $136,489 as of the most recent 13F filing period.
Frequently asked questions
BCTX ownershipBriaCell Therapeutics Corp. (BCTX) is primarily owned by institutional investors, who hold approximately 0.7% of shares. The largest shareholder is CITADEL ADVISORS LLC with a 58.68% stake. Company insiders hold 11.58%. Data sourced from SEC Form 13F as of September 30, 2025.